Skip to main content
. 2024 Nov 13;29(22):5341. doi: 10.3390/molecules29225341

Scheme 3.

Scheme 3

Synthesis of triazole-hybrid scaffolds (AC) and biological profiles (D) of the most potent derivatives. (HELA: cervical cancer cells; MCF-7 and T47D: breast cancer cells; H460: lung cancer cells; HepG2: hepatic carcinoma cells; EA.hy926: vascular endothelial cells; CAKI-1 and A498: renal cancer cells; MCF-10A: non-tumorigenic breast normal cells; Sun: sunitinib).